$0.492
-0.025 (-5.02%)收盤時
- 最高
- 0.556
- 開盤
- 0.483
- 成交量加權均價
- 0.50
- 成交量
- 944.63K
- 市值
- 102.78M
- 最低
- 0.450
- 成交金額
- 471.65K
- 企業價值/稅息折舊攤銷前利潤(TTM)
- 0.00
Zentek Ltd. is an intellectual property technology company. The Company is focused primarily on commercializing ZenGUARD, as well as on the development of certain aptamer technologies and other nanomaterials-based technologies. ZenGUARD is the Company’s patented anti-microbial coating technology platform. Its platform, ZenGUARD, has been shown to have enhanced bacterial and viral filtration efficiency for surgical masks and heating, ventilation, and air conditioning (HVAC) systems. The Company is also focused on the research, development and commercialization of novel products, seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener. The Company has installed industrial-scale production equipment to produce the ZenGUARD coating formulation. The Company is also working on developing processes to synthesize graphene, GO and graphene quantum dots, along with other possible applications for graphene-based materials.
AI 分析 of Zentek Ltd (ZTEK)
賣出Zentek Ltd is not a good buy right now due to its very low RSI of 17.813, indicating it is oversold, and a significant decline of 40.19% over the past year. The company is facing ongoing financial losses, with a net income loss of -3,526,268 CAD in the latest quarter, which raises concerns about its financial health.
估值指標
事件時間軸
資訊
8.505-06Yahoo FinanceZentek Receives New Classification for ZenGUARD Air Filters
2.009-03BenzingaAlphabet Shares Rise Approximately 6%; Check Out 20 Stocks Making Moves in Premarket Trading
3.008-26BenzingaThree Health Care Stocks You Won't Want to Overlook This Quarter
5.007-11SeekingAlphaZentek to not extend CEO's contract
3.007-08Yahoo FinanceTSX Penny Stock Insights: Galleon Gold Among 3 Noteworthy Picks
ZTEK 常見問題 —— 由 Alphio AI 解答
Zentek Ltd. is an intellectual property technology company. The Company is focused primarily on commercializing ZenGUARD, as well as on the development of certain aptamer technologies and other nanomaterials-based technologies. ZenGUARD is the Company’s patented anti-microbial coating technology platform. Its platform, ZenGUARD, has been shown to have enhanced bacterial and viral filtration efficiency for surgical masks and heating, ventilation, and air conditioning (HVAC) systems. The Company is also focused on the research, development and commercialization of novel products, seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener. The Company has installed industrial-scale production equipment to produce the ZenGUARD coating formulation. The Company is also working on developing processes to synthesize graphene, GO and graphene quantum dots, along with other possible applications for graphene-based materials. It operates in the Healthcare sector.
Zentek Ltd is not a good buy right now due to its very low RSI of 17.813, indicating it is oversold, and a significant decline of 40.19% over the past year. The company is facing ongoing financial losses, with a net income loss of -3,526,268 CAD in the latest quarter, which raises concerns about its financial health.
社群
更多 ↗暫無貼文
註冊或登入後參與討論相關文章
- Equal-Weight vs Cap-Weighted S&P 500: RSP vs SPY After October's Rotation and Nvidia's CEO ShockEqual weight vs cap weighted S&P 500: how RSP and SPY differ, why October 2026's rotation was the widest since 2009, and how to blend both after Nvidia's shock.
- Money Market Funds vs High-Yield Savings vs T-Bills: Where to Park Cash as the Fed HikesMoney market funds, high-yield savings or T-bills? Compare November 2026 yields, taxes, FDIC rules and liquidity as the Fed hikes, and build a smart cash plan.
- Homebuilder Stocks With Mortgage Rates Above 7%: An Investor's Guide for Late 2026Homebuilder stocks face 7% mortgage rates and a 16-year low in home sales. See what D.R. Horton, Lennar and Pulte earnings show and how to invest in 2026.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。